A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/Cisplatin and etoposide (PVP) versus sequential administration of CAV‐PVP for the treatment of patients with small cell lung carcinoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.